Semiconductors
A genuine architectural toll-road compounding at 20%+ with a real second engine (Armv9/CSS rate expansion + first-party AGI CPU) — but priced for a decade of flawless execution (~180x GAAP / ~200x non-GAAP P/E, Street mean ~38% below spot) just as it picks a channel-conflict fight with its own licensees and loses the Qualcomm weapon that defined its moat. BULLISH business, BEARISH price — WATCHING for a multiple reset.
Research
The verdict
A genuine architectural toll-road compounding at 20%+ with a real second engine (Armv9/CSS rate expansion + first-party AGI CPU) — but priced for a decade of flawless execution (~180x GAAP / ~200x non-GAAP P/E, Street mean ~38% below spot) just as it picks a channel-conflict fight with its own licensees and loses the Qualcomm weapon that defined its moat. BULLISH business, BEARISH price — WATCHING for a multiple reset.
What it is. Arm Holdings plc is a UK-domiciled (Cambridge, England & Wales) semiconductor IP company — it designs CPU architectures and processor cores and licenses them; it has historically manufactured nothing. It lists as ADRs on Nasdaq (ticker ARM, one ADS = one ordinary share) and files as a foreign private issuer on Form 20-F, not a 10-K. SoftBank Group is the controlling shareholder at ~86.4% of issued share capital, so the public float is ~14% — Arm is a "controlled company" under Nasdaq rules.
How it makes money — two-component model:
Scale. Total FY26 revenue $4,920M (+23% YoY). The architecture is ubiquitous — effectively 100% of smartphones, plus deep penetration in IoT, autos, networking, and a fast-rising data-center share. Mobile applications processors are ~43% of royalty revenue, the mature base; data center and AI are the growth vector.
Customers / suppliers / competitors. Customers are the entire fabless + IDM + hyperscaler world: Apple, Qualcomm, MediaTek, Samsung, NVIDIA, AMD, Amazon (Graviton), Google, Microsoft. "Suppliers" is nearly n/a — Arm is an asset-light IP firm; its true input is R&D engineering talent (~84% of employees are in engineering ). Competitors: the open-source RISC-V ISA (the existential long-term threat), x86 (Intel/AMD) in PCs/servers, and increasingly its own licensees' in-house designs.
Contract structure / key terms. Licenses split into over-time vs point-in-time recognition (FY26 license & other: $1,080M over-time, $1,227M point-in-time ), which makes license revenue lumpy quarter-to-quarter. Royalties accrue on shipment with a one-quarter lag and estimation judgment. Remaining performance obligations (backlog): $2,071.4M, ~28% expected to convert within 12 months — a visibility anchor but small relative to a ~$440B market cap.
Verdict (Lens 1): A rare asset-light, ~98%-gross-margin toll-road on global compute, with an annuity royalty tail and a controlling-shareholder overhang. The model is among the best in semiconductors; the question every other lens probes is whether the price and the strategy pivot respect that.
Arm sits unusually high in the stack — it has almost no physical supply chain of its own, which is the point. Map it:
Upstream (inputs to Arm): EDA tools (Synopsys, Cadence) and IP building blocks; foundry process design kits (TSMC, Samsung, Intel Foundry) that Arm co-optimizes cores against; and human capital (the binding input). No wafers, no fabs, no materials.
Arm (the node): Designs ISAs (Armv8, Armv9), cores (Cortex-A/N/M, Neoverse), and now Compute Subsystems (CSS) — pre-integrated, foundry-optimized core complexes — and a first-party AGI CPU (136-core, data-center).
Downstream (Arm → end customer):
Named chokepoints & single-source dependencies:
Verdict (Lens 2): As a pure-IP firm Arm had no supply chain to break — its FY26 strategic pivot manufactures one. The single most important new dependency on the map is TSMC advanced-node allocation, and the chronic one is the un-consolidated Arm China conduit. Names present, chokepoints marked — lens passes.
The moat, ranked by durability:
Bargaining power. Over suppliers: near-total (Arm buys little). Over customers: high but eroding at the top end — the very largest customers (Apple, Qualcomm, NVIDIA, the hyperscalers) hold architecture licenses that let them build custom cores, capping Arm's pricing leverage over its biggest accounts and giving them a credible RISC-V/in-house exit threat.
Where the moat is thinner than it looks (developed in Lenses 12–13): (a) RISC-V is free and improving; (b) the Qualcomm ruling proved Arm cannot easily weaponize ALA termination to claw back a licensee's custom work; (c) the AGI-CPU pivot converts moat-protecting neutrality into competitive threat.
Verdict (Lens 3): A wide, real moat anchored in ecosystem + a clever per-generation rate escalator — but it is a moat over the licensing business, and management is now spending some of that goodwill to enter the chip business, where the moat is much narrower.
The research-layer segments.csv is empty, so the breakouts below are from the 20-F's disaggregation and geographic notes. Arm reports by revenue type and by geography, not by product division.
By revenue type ($M):
| FY26 | FY25 | FY24 | FY26 YoY | |
|---|---|---|---|---|
| License & other | 2,307 | 1,839 | 1,431 | +25% |
| Royalty | 2,613 | 2,168 | 1,802 | +21% |
| Total | 4,920 | 4,007 | 3,233 | +23% |
Of license & other, related-party (Arm China et al.) is $1,009M of $2,307M; of royalty, related-party is $490M of $2,613M. Royalty acceleration is mix-driven, not volume-driven — "improved mix of products with higher royalty rates per chip, such as Armv9" — exactly the rate-escalator thesis. Data-center royalty "more than doubled year-over-year" in Q4.
By geography ($M, by customer HQ):
| Region | FY26 | FY25 | FY24 | Note |
|---|---|---|---|---|
| United States | 1,761 | 1,716 | 1,413 | largest, slow-growing |
| PRC | 874 | 749 | 697 | ~18% of total; the geopolitical line |
| Japan | 825 | 296 | 121 | +179% YoY — the standout |
| Taiwan | 695 | 629 | 522 | foundry/fabless hub |
| Republic of Korea | 392 | 324 | 308 | Samsung/SK |
| Other | 373 | 293 | 172 |
The signal: Japan revenue nearly tripled (FY25→FY26) and is up ~7x off FY24 — almost certainly SoftBank-adjacent / AI-datacenter (e.g., SoftBank's own AI ambitions, Rapidus, and AGI-CPU lead activity). It is now Arm's #2–3 geography from a rounding error two years ago. Worth watching whether it is durable customer demand or related-party concentration.
Verdict (Lens 4): Royalty growth is high-quality (rate/mix, not units); the Japan surge is the most interesting under-discussed line; and the segment data confirms the bull engine — value-stack migration — is real in the actuals, not just the deck.
Full-year FY26 (ended 31 Mar 2026) ]:
| ($M) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Total revenue | 4,920 | 4,007 | 3,233 |
| Cost of sales | (121) | (121) | (154) |
| Gross profit | 4,799 (98%) | 3,886 (97%) | 3,079 (95%) |
| R&D | (2,776) (56%) | (2,071) (52%) | (1,979) (61%) |
| SG&A | (1,115) (23%) | (984) (25%) | (983) (30%) |
| Operating income | 900 (18%) | 831 (21%) | 111 (3%) |
| Net income | 904 (18%) | 792 (20%) | 306 (9%) |
| Diluted EPS (GAAP) | $0.85 | $0.75 | $0.29 |
| Non-GAAP EPS | $1.77 | n/a (prior yr) | n/a |
Q4 FY26 specifically: Revenue $1.49B (+20%), a record and above guidance midpoint. Licensing $819M (+29%); Royalty $671M (+11%), with data-center royalty more than doubling. Record non-GAAP EPS $0.60.
Beat/miss & reaction: The print beat on revenue and EPS — and the stock fell ~7.25% to $220.10 on 7 May 2026. Two reasons: (1) smartphone unit growth guided negative on a memory-chip shortage rippling through the handset supply chain; (2) the AGI-CPU opportunity was huge in demand ($20B+) but capped in supply ($1B locked), so the near-term revenue print didn't move enough to satisfy a stock priced for perfection.
Margin read: Gross margin is structurally ~97–98% (pure IP). The real operating story is R&D rising to 56% of revenue — Arm is deliberately spending its operating leverage to fund the AGI-CPU roadmap. GAAP operating margin fell (21%→18%) even as revenue grew 23%, because R&D grew faster. That is a choice, and the bull/bear hinges on whether it pays off.
Balance-sheet flags: Cash & equivalents $2,751M + $850M short-term investments ≈ $3.6B, effectively net-cash, no meaningful debt. Accounts receivable $1,331M (up from $1,127M) — rising with revenue, watch the royalty-estimation accrual (Lens 10). FY26 had a $253M tax expense vs a benefit in FY24–FY25, which masked some of the pre-tax improvement at the net line.
Anomaly vs own history: Beating and dropping 7% is the tell of an expectations problem, not a business problem — the recurring FY26 pattern (see Lens 8).
Verdict (Lens 5): A genuinely strong, accelerating, ~98%-gross-margin print — undercut near-term by a memory-driven smartphone air-pocket and a supply-capped (not demand-capped) AGI ramp. The business is firing; the stock reaction shows the bar is the risk.
No transcripts on disk; this lens is ``-grounded from FY26 call coverage and CEO interviews.
What management is focused on (FY26 arc): The narrative has shifted hard from "we license IP" to "we are becoming a CPU maker." CEO Rene Haas's recurring 2026 themes:
Tone shift over time: Through FY25 the tone was "neutral IP partner riding everyone's growth." Through FY26 it became assertive, competitive, almost combative toward x86 and implicitly toward its own licensees. Confidence is high and the TAM claims are escalating (Bernstein lifted Arm's own framing to a $223B CPU TAM by 2030 ).
What they stopped saying: Less emphasis on "neutral Switzerland of silicon" — the positioning that historically reassured Apple/Qualcomm/NVIDIA. That omission is the channel-conflict risk surfacing in the language.
Verdict (Lens 6): Sentiment is euphoric and the strategy is bold — but the rhetorical pivot from neutral arms-dealer to competitor is the single most important qualitative change, and it cuts both ways.
| Company | Ticker | Mkt cap | P/E | EV/Sales | Note |
|---|---|---|---|---|---|
| Arm Holdings | ARM | ~$440B | ~178x GAAP / ~200x non-GAAP | ~90x | IP licensor priced as hyper-growth |
| NVIDIA | NVDA | n/a (this run) | ~40–50x | — | end-market peer, far cheaper on growth |
| Broadcom | AVGO | n/a | ~40x range | — | custom-silicon + IP |
| AMD | AMD | n/a | ~40x range | — | x86/accelerator peer |
| Synopsys | SNPS | n/a — not in index | ~50–60x | — | closest model comp (IP/EDA) |
| Cadence | CDNS | n/a — not in index | ~60–70x | — | closest model comp (IP/EDA) |
| Industry avg (non-GAAP P/E) | — | — | ~24x | — | the gravity line |
The comp verdict: On any peer set Arm is the most expensive name by a wide margin — ~200x non-GAAP vs a ~24x semis industry average, and roughly 3–4x the EDA licensors that share its model. Even versus NVIDIA (faster absolute growth, fatter dollar profits), Arm trades at a multiple premium. The market is paying for optionality (AGI CPU + Armv9 rate ramp), not current earnings. Dividend yield: 0% — Arm pays no dividend. 5-yr average ROE: n/a (only a ~2.5-yr public history since the Sept-2023 IPO; ROE is volatile given the FY24 near-breakeven and IPO-related SBC).
Arm has only traded publicly since 14 Sept 2023 (IPO at $51, popped ~25% day one; SoftBank retained ~90.6%, now 86.4%). The >5%-move catalyst pattern:
What the market actually reacts to: (1) royalty/guidance trajectory, (2) AGI-CPU TAM and customer wins, (3) the gap between euphoric sell-side targets and a fundamentally rich multiple. It does not reward trailing beats — the bar is always the next leg of the AI story.
Verdict (Lens 8): A momentum/narrative stock. Catalysts are earnings guidance, AGI-CPU milestones, and analyst-target leapfrogging. That makes it a story stock with a fundamental floor far below spot — fragile to any narrative crack.
CEO — Rene Haas (CEO since Feb 2022).
insider-transactions.csv not present — individual exec holdings n/a.Verdict (Lens 9): A strong, credible operator executing an aggressive, coherent strategy — with two governance caveats that the valuation does not discount: SBC that consumes most of GAAP profit, and an 86%-owner whose agenda sets the direction.
Forensic lens — every figure labeled.
Income statement.
Balance sheet.
Cash flow vs earnings: FCF not in research-layer (capex-detail.csv empty); as a near-zero-capex IP firm, FCF should track net income closely — but the SBC add-back inflates operating cash flow relative to true owner earnings. n/a for the exact FY26 FCF figure (would need the cash-flow statement; not extracted).
Regulatory findings (required sub-section). Read regulatory/regulatory-findings.md.
Verdict (Lens 10): Books are clean of enforcement history; the genuine forensic caution is the estimate-driven royalty accrual and SBC > GAAP operating income (a quality-of-earnings flag for anyone leaning on non-GAAP). The bigger risks are regulatory/legal, not accounting.
Anchor (actuals + guidance): FY26 revenue $4,920M, non-GAAP EPS $1.77. Q1-FY27 guided: revenue ~$1.26B (+~20%), non-GAAP EPS $0.40 ±$0.04. Management frames FY27 royalty growth ~20%/qtr and licensing ~60% H2-weighted.
Build (every input labeled; output ``):
| FY27E | FY28E | FY29E | Drivers | |
|---|---|---|---|---|
| Revenue growth | ~+22% | ~+25% | ~+25% | Royalty +20% (Armv9/CSS mix), license +25%, AGI-CPU immaterial until FY28+ |
| Revenue ($B) | ~$6.0 | ~$7.5 | ~$9.4 | |
| Non-GAAP op margin | ~flat→down | recovering | recovering | R&D stays elevated near-term for AGI-CPU, then leverages |
| Non-GAAP EPS | ~$2.15 | ~$2.85 | ~$3.70 |
The valuation math that matters: At ~$439 and base FY27 EPS ~$2.15, ARM trades at ~205x forward non-GAAP. To "grow into" even a still-rich 50x by FY29, EPS must roughly quadruple from here and the multiple must compress 75% — both have to go right. Even Bernstein's bullish $500 implies the market cap ($530B) is ~110x FY27 non-GAAP. The Street's mean target sits ~38% below the spot price — i.e., the median analyst thinks the stock is ~38% too high even while the marginal buyer keeps bidding.
Forecast logging: Per --watchlist rules, no forecast.ts create in this unattended breadth pass (only log a Brier forecast on a genuinely committed base case). If promoted to a thesis, the natural scoreable forecast would be: "ARM FY27 (ending Mar-2027) non-GAAP EPS ≥ $2.15, p≈0.55, resolves 2027-03-31." Not logged here.
Bull case. Arm is the toll-road on all of computing, and the toll-per-vehicle is rising on its own engineering cadence (Armv8→v9→CSS lifts ASP royalty from ~3% → 5% → 10% ) with Armv9 only ~25% penetrated against a 60–70% target — so royalties compound even if unit volumes stall. Layer on a second engine: the AGI CPU turns Arm from a ~3-cents-on-the-dollar IP licensor into a seller of whole chips, with disclosed demand already >$20B and marquee customers (Meta lead; OpenAI, Oracle, ByteDance, Cerebras, Cloudflare, SK Telecom). Power-efficiency is the structural tailwind: AI data centers are power-bound, and Arm's perf/watt is its weapon against x86. ~98% gross margins, net cash, an installed base of >350B chips, and a controlling owner (SoftBank) funding a decade-long bet. If AGI CPU even half-works, Arm's revenue path to $25B by FY31 re-rates the whole story.
Bear case (2–3 permanent-impairment risks).
Pre-mortem (18 months out, thesis broke — what happened?): AGI-CPU supply stayed capped (TSMC allocation lost to NVIDIA/Apple), so the second engine slipped to FY29; the memory-shortage smartphone air-pocket dragged two quarters of royalty growth below 20%; an FTC action or a high-profile RISC-V defection (a top hyperscaler moving a flagship line off Arm) cracked the narrative — and a story stock at 200x re-rated to 80x, a ~55% drawdown, with earnings still growing.
Are multiples too high? Yes, on any historical or peer frame — the only justification is the optionality value of the AGI-CPU TAM, which is real but unproven and years from materiality.
Contrarian view (what the market refuses to see): Bulls treat the AGI-CPU pivot as pure upside. The contrarian read is that the pivot is partly defensive and partly self-cannibalizing — Arm is moving into chips because the licensing model's pricing power over its biggest customers has peaked (they all hold architecture licenses and can build their own), and in doing so it converts its best customers into competitors and regulators' targets. The thing that makes the bull deck exciting is the same thing that threatens the annuity.
Dismantling the bull case.
Verdict (Lens 13): The short case isn't "the business is bad" — it's "the price assumes a flawless decade while management lights a channel-conflict fire and the courts just weakened the moat." It's a valuation + strategy-risk short, not a fraud short.
SKYT is no longer a foundry — it is an IonQ deal-stub trading $38.40 vs a $35.00 closed-vote merger value, i.e. a +10% premium that is pure leveraged FTC-cleared bet on IonQ rallying past $60.13; the standalone foundry (43% Infineon, negative op cash flow, $22M cash) is the break-case floor, not the thesis.
The MEMS-timing monopolist is being bid as if it has already won the AI clock — at ~35x sales and ~85x forward earnings, a flawless +88% quarter and the transformational Renesas deal are not just priced in, they are required.
This is no longer a chip stock — it's a near-closed merger-arb. TI buys SLAB for $231 cash; HSR cleared and shareholders approved, only China SAMR left, ~6% gross spread to close in 1H2027. The trade is deal certainty, not IoT growth.